期刊文献+

新生儿感染性肺炎病原菌85例临床分析

Clinical analysis of 85 cases of pneumonia pathogen infection in neonates
下载PDF
导出
摘要 目的:了解新生儿感染性肺炎患者病原菌及药敏实验结果,为临床治疗提供依据。方法:2010年1月-2013年6月收治新生儿感染性肺炎患儿,对其痰培养和药敏进行分析。结果:新生儿感染性肺炎的患儿中送检373例痰标本,其中痰培养阳性85例,阳性率22.8%。常见病原菌依次是大肠埃希菌、肺炎克雷伯菌、金黄色葡萄球菌等。85株药物敏感试验结果:革兰阴性杆菌对β-内酰胺加酶抑制剂(哌拉西林他唑巴坦、阿莫西林舒巴坦、头孢哌酮舒巴坦)及氨基糖苷类药物较敏感。金黄色葡萄球菌对苯唑西林较敏感。无万古霉素耐药株。结论:所培养检出的致病菌中,以革兰阴性杆菌占主导地位,主要为大肠埃希菌和肺炎克雷伯菌。革兰阳性球菌主要是金黄色葡萄球菌及凝固酶阴性葡萄球菌。药敏结果显示,大肠埃希菌、肺炎克雷伯菌等杆菌对β-内酰胺加酶抑制剂、丁胺卡那敏感;葡萄球菌对苯唑西林较敏感。 Objective:To understand the pathogenic bacteria and drug sensitivity test results of neonatal infection pneumonia patients,and to provide the basis for clinical therapy.Methods:Neonatal infection pneumonia patients were selected from January 2010 to June 2013.Sputum culture and sensitivity results were analyzed.Results:In the neonatal infection in children with pneumonia,373 cases of sputum specimens were submitted,among them,85 cases of sputum culture were positive,and the positive rate was 22.8%.Common pathogens were escherichia coli,klebsiella pneumoniae,staphylococcus aureus and so on.85 strains of drug sensitive test results:gram negative bacilli was sensitive to beta lactam enzyme inhibitor(piperacillin tazobactam,amoxicillin sulbactam and cefoperazone sulbactam) and aminoglycosides.Staphylococcus aureus was sensitive to oxacillin.There was no vancomycin resistant strains.Conclusion:In the culture of pathogenic bacteria detection,G- bacillus was the dominant,they were mainly escherichia coli and klebsiella pneumoniae.G+ cocci mainly staphylococcus aureus and coagulase negative staphylococcus. The drug sensitivity results showed,escherichia coli,klebsiella pneumonia were sensitive to beta lactam enzyme inhibitors and amikacin;staphylococcus was sensitive to oxacillin.
出处 《中国社区医师》 2015年第12期62-62,64,共2页 Chinese Community Doctors
关键词 新生儿 感染性 肺炎 病原菌 临床分析 The newborn Infection Pneumonia Pathogen Clinical analysis
  • 相关文献

参考文献2

二级参考文献25

  • 1BRIEN OTF.The global epidemic of antimicrobialresistance and the need to monitor and manage it locally[J].Clin Infect Dis,1997,24:S2-8.
  • 2Tenover FC,Biddle JW,Lancaster MV. Increasing resistance to vancomycin and other Glycopeptides in Staphylococcus aureus [ J]. Emerging Infect Dis,2001,7:327-332.
  • 3Jolanta KR, Marek G, Hanna PP, et al. The first staphylococcus aureus isolates with reduced susceptibility to vancomycin in Poland [ J ]. J Antimicrob Chemother ,2002,50:1065-1069.
  • 4Chang S, Sienert DM, Hageman JC, et al. Infection with vancomycin-resistant staphylococcus aureus containing the vanA resistance gene[ J]. N Engl J Med,2003,348:1342-1347.
  • 5World Health Organization. Perinatal mortality: a listing of available information[ R ]. FRH/MSM-96-7. Geneva: WHO, 1996.
  • 6Schuehat A, Hilger T,Zell E, et al, Active bacterial core surveillance of the emerging infections program network [ J ]. Emerging Infect Dis ,2001,7 (1) :92-99,
  • 7Hsueh PR, Chen ML,Sun CC, ct al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981-1999 [ J ]. Emerging Infectious Diseases,2002,8 ( 1 ) :63-68.
  • 8朱建国.微生物的检验方法//叶应妩,王毓三.全国临床检验操作规程[M].2版.沈阳:东北大学出版社,1997:472-550.
  • 9National Committee for Clinical Laboratory Standards. Performance standards for antimicroblal susceptibility testing: fourteenth informational supplement. M100-S14 [ S]. Wayne, Pennsylvania 19087-1898 USA,2004.
  • 10Kloos WE, Bannerman TL. Update on clinical significance of coagnlase-negative staphylococci[ J ]. Clin Microbiol Rev, 1994,7 :117-140.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部